DCM
CERE

DAFNA Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

DAFNA Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-62,200
Closed -$1.36M – 82
2023
Q3 		$1.36M Buy
+62,200
New +$1.36M 0.42% 45